Skip to main content
DIRUI INDUSTRIAL CO.,LTD. logo

DIRUI INDUSTRIAL CO.,LTD. — Investor Relations & Filings

Ticker · 300396 ISIN · CNE100001XS7 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,689 across all filing types
Latest filing 2022-04-28 Report Publication Anno…
Country CN China
Listing Shenzhen Stock Exchange 300396

About DIRUI INDUSTRIAL CO.,LTD.

https://www.dirui.com.cn

DIRUI INDUSTRIAL CO.,LTD. specializes in the research, development, manufacturing, and distribution of medical laboratory instruments and diagnostic reagents. The company provides comprehensive solutions for in-vitro diagnostics (IVD), focusing on several key clinical areas including urinalysis, biochemistry, hematology, and chemiluminescence immunoassay. Its product portfolio features high-throughput automated analyzers and integrated laboratory systems designed to enhance diagnostic efficiency and accuracy. DIRUI serves a global market, providing medical institutions and laboratories with a wide range of diagnostic tools, from urine sediment analysis to vaginal secretion testing. The company emphasizes technological innovation and quality control to support clinical decision-making and patient care through reliable laboratory automation and standardized testing protocols.

Recent filings

Filing Released Lang Actions
关于举行2021年度报告网上业绩说明会的公告
Report Publication Announcement Classification · 95% confidence The document is an announcement about holding an online performance explanation meeting related to the 2021 Annual Report. It mentions that the 2021 Annual Report has already been disclosed on April 29, 2022, and this notice is about the upcoming online meeting to discuss that report. The document is short (904 characters) and serves as a notice for an event rather than the report itself. According to the 'Menu vs Meal' rule, this is a report publication announcement or related event notice, not the Annual Report itself.
2022-04-28 Chinese
关于公司拟续聘会计师事务所的公告
Audit Report / Information Classification · 95% confidence The document is an announcement regarding the company's intention to renew the appointment of its external audit firm for the 2022 fiscal year. It details the audit firm's background, qualifications, independence, and the approval process by the board and independent directors. There are no actual financial statements or audit results included, only information about the audit firm and the approval process. The document length is about 3,000 characters, which is relatively short and consistent with an announcement rather than a full audit report. Therefore, this document is best classified as an Audit Report / Information announcement (AR) because it relates to audit matters but does not contain the full audit report or financial statements themselves. FY 2022
2022-04-28 Chinese
2022年一季度报告
Interim / Quarterly Report Classification · 100% confidence The document is titled "2022 年第一季度报告全文" which translates to "2022 First Quarter Report Full Text." It contains detailed financial data including income statement, balance sheet, cash flow statement, and notes on financial performance for the first quarter of 2022. The document explicitly states it is a quarterly report and includes comprehensive financial statements and analysis. It also mentions that the report is unaudited. The length of the document (13,537 characters) and the detailed financial data confirm it is a full interim/quarterly report rather than a brief announcement or summary. Therefore, the document fits the definition of an Interim / Quarterly Report (IR). Q1 2022
2022-04-28 Chinese
董事会决议公告
Board/Management Information Classification · 95% confidence The document is a detailed announcement of resolutions passed at the fifth meeting of the fifth board of directors of Dirui Medical Technology Co., Ltd. It includes approvals of various reports such as the 2021 annual general manager work report, 2021 annual board work report, 2021 financial report, profit distribution plan, and other governance-related proposals. The document also mentions that many of these reports and documents are available on the official information disclosure website (cninfo.com.cn) and that these resolutions will be submitted to the 2021 annual shareholders meeting for approval. The document is not the actual annual report or financial statements but rather a formal announcement of board meeting decisions and approvals related to the annual report and other governance matters. It also includes announcements of appointments and changes in management. Given the nature of the content—board meeting resolutions including management reports, financial report approvals, and governance matters—the best classification is Board/Management Information (MANG). The document is not a full annual report (10-K), nor is it a simple announcement of a report publication (RPA), as it contains substantive board decisions and approvals. Therefore, the classification is MANG with high confidence.
2022-04-28 Chinese
关于聘任高级管理人员的公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the appointment of senior management personnel, specifically the hiring of two vice general managers. It includes details about the individuals' backgrounds and confirms the board's approval. There is no financial data, report, or regulatory filing referenced beyond the appointment. This fits the category of Board/Management Information (MANG), which covers announcements of changes in senior management.
2022-04-28 Chinese
监事会决议公告
Regulatory Filings Classification · 95% confidence The document is a resolution announcement from the Supervisory Board of Dirui Medical Technology Co., Ltd. It details the approval of various reports and proposals including the 2021 Supervisory Board Work Report, 2021 Annual Report and its summary, 2021 Financial Final Accounts Report, 2021 Profit Distribution Plan, 2021 Internal Control Self-Evaluation Report, adjustments to the 2021 Restricted Stock Incentive Plan, reduction of registered capital, reappointment of the 2022 audit firm, and the 2022 Q1 Report. The document repeatedly states that the detailed contents of these reports are available on an external website (cninfo.com.cn) and that these resolutions need to be submitted to the 2021 Annual General Meeting for approval. The document itself does not contain the full reports or substantive financial data but rather announces the resolutions passed by the Supervisory Board regarding these reports and plans. The document length is 4091 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, this document is best classified as a Regulatory Filing (RNS) because it is an official announcement of resolutions and approvals related to various reports and plans, not the reports themselves.
2022-04-28 Chinese

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.